Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

Hiroyuki Konya, Yuzo Yano, Satoshi Matsutani, Taku Tsunoda, Takashi Ikawa, Yoshiki Kusunoki, Toshihiro Matsuo, Masayuki Miuchi, Tomoyuki Katsuno, Tomoya Hamaguchi, Jun-ichiro Miyagawa, Mitsuyoshi Namba
  • Therapeutics and Clinical Risk Management, July 2014, Taylor & Francis
  • DOI: 10.2147/tcrm.s46076

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/tcrm.s46076

The following have contributed to this page: Mitsuyoshi Namba